Biotech startup Ahammune Biosciences has raised $5 Mn (about INR 41 Cr) in its Series A round led by pi Ventures.

Multiple Late-Breaking Data Presentations from Incyte’s Dermatology Portfolio will be Featured at the EADV 2024 Congress ...

The funding will enable the company in conducting Phase II human clinical trials for its potential drug candidate for ...

The biotech startup will use the funds to assist its Phase II human clinical trials for its drug candidate for vitiligo.

Biotech startup Ahammune Biosciences has raised $5 million in Series A funding round led by pi Ventures. The round also ...

Celebrating the success of the Albinism Society of South Africa (ASSA) fundraising event held at Birchwood Hotel recently are ...

Clinical stage therapeutics startup Ahammune Biosciences, bread brand The Health Factory, proptech startup Flent and ...

Drug maker AbbVie (ABBV) announced Wednesday positive results from a new post-hoc analysis of Phase 3 Studies, demonstrating efficacy ...

We often view celebrities as flawless beings due to their access to makeup, glam squads, and even cosmetic surgeries. Ho ...

AbbVie (NYSE: ABBV) today announced positive results from a new post-hoc analysis from the Measure Up 1 and Measure Up 2 Phase 3 studies. The analysis evaluated the efficacy of upadacitinib (15 mg or ...

Provided at no cost to the families, Camp Discovery is one week of fun for kids with conditions ranging from eczema and psoriasis, to vitiligo and alopecia, to epidermolysis bullosa and ichthyosis.